Factor VIII biosimilar (AXXO)

凝血因子VIII生物类似药 (AXXO)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor VIII biosimilar (AXXO)

Drug Alias Name凝血因子VIII生物仿制药 (AXXO)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factorBiologics > Biosimilar

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation

TargetsCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesAxxo

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAxxo

Active IndicationsN/A

Inactive IndicationsHemophilia A

ATC CodeB02BD02